The promise of retinoids to fight against cancer
The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Abstract
Retinoids have a reputation for being both detrimental and beneficial: they are teratogens, but they also have tumour-suppressive capacity. Cell biology and genetics have significantly improved our understanding of the mechanisms that underlie the anti-proliferative action of retinoids. Recent elucidation of the pathways that are activated by retinoids will help us to exploit the beneficial aspects of this powerful class of compounds for cancer therapy and prevention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Apart from the well-known indications in hypovitaminosis and skin diseases, retinoids have been successfully used in treating cancer”
From Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity (2021) · cites this paper as [187]
In the citing paper
“The FDA has approved ATRA to treat cystic acne and several cancers, such as some lymphoma and leukemia”
From Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity (2021) · cites this paper as [187]
Citations
Cites
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233 · cited 8×
“a | The t(15;17) chromosomal translocation generates the PML–RARα fusion protein that, in contrast to RARα, can efficiently dimerize or oligomerize, thereby recruiting multiple HDAC complexes and leading to ‘super-repression’ of target genes.”
BackgroundInfluentialKamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S.-C., Heyman, R. A., Rose, D. W., Glass, C. K., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81118-6 · Cited by 2,150
Matthay, K. K., Villablanca, J. G., Seeger, R. C., Stram, D. O., Harris, R. E., Ramsay, N. K., Swift, P., Shimada, H., Black, C. T., Brodeur, G. M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910143411601 · Cited by 1,898
ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics
McPherson, K. (2000) · BMJ · doi:10.1136/bmj.321.7261.624 · Cited by 1,570
Hong, W. K., Lippman, S. M., Itri, L. M., Karp, D. D., Lee, J. S., Byers, R. M., Schantz, S. P., Kramer, A. M., Lotan, R., Peters, L. J., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199009203231205 · Cited by 1,365
The retinoids—Biology, chemistry and medicine
(1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)80793-5 · Cited by 1,178
Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed Cells
Marks, P. A., Richon, V. M., & Rifkind, R. A. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1210 · Cited by 1,157
Embryonic retinoic acid synthesis is essential for early mouse post-implantation development
Niederreither, K., Subbarayan, V., Dollé, P., & Chambon, P. (1999) · Nature Genetics · doi:10.1038/7788 · Cited by 1,077
Role of the histone deacetylase complex in acute promyelocytic leukaemia
Lin, R. J., Nagy, L., Inoue, S., Shao, W., Miller, W. H., & Evans, R. M. (1998) · Nature · doi:10.1038/35895 · Cited by 1,062 · cited 1×
“However, high concentrations of HDAC inhibitors (HDACi) can convert even PLZF–RARα into an activator of the RA signalling pathwa”
BackgroundGrignani, F., De Matteis, S., Nervi, C., Tomassoni, L., Gelmetti, V., Cioce, M., Fanelli, M., Ruthardt, M., Ferrara, F. F., Zamir, I., et al. (1998) · Nature · doi:10.1038/35901 · Cited by 1,004 · cited 1×
“However, high concentrations of HDAC inhibitors (HDACi) can convert even PLZF–RARα into an activator of the RA signalling pathwa”
Background
Research works printed but not linked: 1
- Moon, R. C., Mehta, R. G. & Rao, K. J. V. N. in The Retinoids (eds Sporn, M. B., Roberts, A. B. & Goodman, D. S.) 573–595 (Raven, New York, 1994).
Cited by
Items 701–784 of 784
Cardozo, M. T. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2011.tde-14092012-101247
Wright, S. K. (2012) · University of Minnesota Digital Conservancy (University of Minnesota)
Touma, S. E., Gudas, L. J., Nanus, D. M., & Tickoo, S. K. (2005) · doi:10.21236/ada435095
Functional genetic screens as tools to discover signaling pathways targeted by cancer drugs
Epping, M. T. (2008) · Utrecht University Repository (Utrecht University)
Bengtsson, Å. (2009) · Lund University Publications (Lund University)
DUAL TRANSCRIPTIONAL ACTIVITIES UNDERLIE OPPOSING EFFECTS OF RETINOIC ACID IN MAMMARY CARCINOMA
Thad, S. (2007) · eCommons (Cornell University)
Effects of Natural and Synthetic Retinoids on the Differentiation and Growth of Squamous Cancers
Kadara, H. N., & Lotan, R. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7203-3_13
Bases moleculares e efeitos de retinóides em células tumorais
Costa, S. L. (2004) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.9771/cmbio.v3i2.4428
Epigenetic Targeting and Histone Deacetylase Inhibition in RCC
Ramakrishnan, S., & Пили, Р. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2400-0_9
Vitamin D 3 metabolism in normal and malignant human prostate cells
Lou, Y. (2005) · Tampere University Institutional Repository (Tampere University)
Chemopreventive anti-cancer agent acyclic retinoid suppresses allogeneic immune responses in rats
Ohsawa, I., Murakami, T., Guo, L., Enosawa, S., Ishibashi, N., Isaji, S., Üemoto, S., & Kobayashi, E. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.04.017
O’Byrne, S. M. (n.d.) · ProQuest Demo Repository
Carotenoids with two chromophores: carotenoid retinoates
Hertzberg, S., Lutnæs, B. F., & Jensen, S. L. (2011) · Natural Product Research · doi:10.1080/14786419.2010.488629
“…there is considerable evidence for natural and synthetic retinoids being effective in the prevention and treatment of various chronic diseases, including cancer (Altucci & Gronemeyer, 2001), through their ability to regulate gene expression (Duester, 2008; Fields, Soprano, & Soprano, 2007).”
BackgroundJames, S. Y., Lin, F., Kolluri, S. K., Dawson, M. I., & Zhang, X.-K. (2003)
Kratz, A. (2015) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-4972
Leclerc, D., Lévesque, N., & Cao, Y. (2013)
Stat3 and Tumor Cell Proliferation
Fakultät, P.-N. (2004)
Saavalainen, K. (2007) · Cited by 1
Degaki, T. L. (2006) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2006.tde-01112006-094510
“…consiste na utilização de compostos que atuem no restabelecimento de vias inibitórias de proliferação associada à diferenciação celular, como, por exemplo, o ácido retinóico e seus derivados, que são utilizados como agentes terapêuticos em cânceres hematológicos (Altucci & Gronemeyer, 2001).”
Chemoprevention of Hepatocellular Carcinoma with Retinoid
Moriwaki, H. (2004) · Springer eBooks · doi:10.1007/978-4-431-53977-3_23
Zambrano, A., Sánchez‐Pacheco, A., & Aranda, A. (2007)
Vitamins In Hepatocellular Carcinoma
Tamori, A., & Shiomi, S. (2009) · CRC Press eBooks · doi:10.1201/9781420085501.ch16
Wang, X. (2006) · CRC Press eBooks · doi:10.1201/9781420004847-7
Retinoids in the Prevention and Treatment of Skin Cancer
Drucker, C. R. (2007) · Basic and clinical dermatology · doi:10.3109/9781420021189.012
Barra, C. N. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.10.2016.tde-27102015-111101
Liu, Z., Wen, J., & Xu, C. (2017) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2017.01.011
Padovani, K. S. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.60.2017.tde-23052017-142507
Level of Retinol Deposit and Cervical Cancer
Utami, T. W., Ibrahim, F., Purwoto, G., Tiffani, W. L., Aziz, M. F., & Andrijono, A. (2017) · Indonesian Journal of Obstetrics and Gynecology · doi:10.32771/inajog.v5i1.465
Factores genéticos y epigenéticos del cáncer gástrico
de Antioquia, U., & Pérez‐Cala, T. L. (2017) · Actualidades Biológicas · doi:10.17533/udea.acbi.v39n106a01 · Cited by 6
Epigenetic Dysregulation in Pediatric Leukemia
Madhusoodhan, P. P., Carroll, W. L., & Bhatla, T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809552-2.00001-2
Chesnut, C., Rubin, A. G., Martin, S., Diehl, J. W., & Soriano, T. T. (2014) · Springer eBooks · doi:10.1007/978-3-319-12445-2_6
Prescription for transcription
Novak, K. D. (2001) · Nature reviews. Cancer · doi:10.1038/35106030
Nguyen, P. H., Thu Ha, N. G. O., & Luu, T. B. (2018) · VNU Journal of Science Natural Sciences and Technology · doi:10.25073/2588-1140/vnunst.4787
Papavassiliou, A. G., & Karamouzis, M. V. (2011) · Springer eBooks · doi:10.1007/978-3-642-16483-5_5073
Chemoprevention of Lung Cancer
Cohen, V., & Khuri, F. R. (2006) · Springer eBooks · doi:10.1007/3-540-31040-1_53
Yurdakök-Dikmen, B., Filazı, A., & İnce, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89773-0.00023-0
Papavassiliou, A. G., & Karamouzis, M. V. (2008) · Springer eBooks · doi:10.1007/978-3-540-47648-1_5073
Offermanns, S. (2012) · Springer-Lehrbuch · doi:10.1007/978-3-642-12354-2_53
Effects of Carotenoid Supplementation on Signal Transduction Pathways
Wang, X., & King, S. (2006) · CRC Press eBooks · doi:10.1201/9781420004847.ch7
Retinoic acids in oral precancer: Utility and challenges
Pandey, R. K., & Mehrotra, D. (2020) · Journal of Oral and Maxillofacial Surgery Medicine and Pathology · doi:10.1016/j.ajoms.2020.03.013
The Mysterious Chemo-Preventive Player in Oral Cavity: Retinoids
Mohanty, G. (2020) · Indian Journal of Forensic Medicine & Toxicology · doi:10.37506/ijfmt.v14i4.12925
Jia, J. H., Li, D., Zhang, D., Cai, J., Li, F., & Duan, X. (2022) · Research Square · doi:10.21203/rs.3.rs-1914393/v1
Retinoic Acid Receptors and their Modulators: Structural and Functional Insights
le Maire, A., Bourguet, W., Gronemeyer, H., & de Lera, Á. R. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849733687-00417
Self-citationVitamin A: Three Vitamer Forms: Retinol, Retinal, and Retinoic Acid
Walsh, C. T., & Tang, Y. (2018) · Royal Society of Chemistry eBooks · doi:10.1039/bk9781788014649-00330
Nefedova, Y., Fishman, M., Sherman, S., Wang, X., Beg, A. A., & Gabrilovich, D. I. (2023) · doi:10.1158/0008-5472.c.6496655
Data from Molecular Determinants of Retinoic Acid Sensitivity in Pancreatic Cancer
Gupta, S., Pramanik, D., Mukherjee, R., Campbell, N. R., Elumalai, S., de Wilde, R. F., Hong, S., Goggins, M., Jesus‐Acosta, A. D., Laheru, D. A., et al. (2023) · doi:10.1158/1078-0432.c.6520908
Retinoids and EZH2 inhibitors cooperate to orchestrate cytotoxic effects on bladder cancer cellsPreprint
Ozgun, G., Yaraş, T., Landman, N., Karakülah, G., van Lohuizen, M., Şentürk, Ş., & Ozhan, S. E. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.19.537500
Su, X., Zhou, Z., Chen, W., Zhu, M., Wu, L., Yin, Y., Chen, S., & Kang, M. (2023) · Research Square · doi:10.21203/rs.3.rs-2930454/v1
Patitungkho, S., & Patitungkho, K. (2024) · Open Journal of Medicinal Chemistry · doi:10.4236/ojmc.2024.141001
Retinoids and the Vitamin a Receptor STRA6 in Health and Disease
Dhokia, V., & Macip, S. (2024) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-55489-6_13
Chen, F., Cai, Y., Chen, X., & Zhou, J. (2024) · Research Square · doi:10.21203/rs.3.rs-4515414/v1
Fat Soluble Vitamins and Macrominerals
Polat, E. (2024) · doi:10.69860/nobel.9786053359173.1
Krishna, S., & Kumari, M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.30.662295
Expression and regulation of retinoic acid receptors in breast cancer
Haq, B. U., Mir, A. A., Masoodi, G., & Mir, M. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-36516-4.00015-5
Rossetto, D. D. B. (2012) · Aleph UCLA Undergraduate Research Journal for the Humanities and Social Sciences
Epigenetic of Retinoic Acid Receptor β2 Gene in Breast Cancer
Mehdipour, P. (2015) · Springer eBooks · doi:10.1007/978-94-017-9639-2_11
Epigenetic regulation of gene transcription in hematopoietic tumors.
Tshuikina, M. (2008) · DiVA (Digitala Vetenskapliga Arkivet)
Liu, X., Shan, W., Li, T., Gao, X., Kong, F., You, H., Kong, D., Qiao, S., & Tang, R. (2021) · Figshare · doi:10.6084/m9.figshare.17010118
Efficiency of all-trans retinoic acid on gastric cancer
Hajipour, M., Mokhtari, K., & Peymani, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-22305-1.00015-1
γc-cytokines in HIV Cure Research
Melo, C., Lochner, J. S., & Bosque, A. (2026) · Current Opinion in HIV and AIDS · doi:10.1097/coh.000000000000102
Dihydromyricetin attenuates LPS-induced liver injury in chicks through the JNK signaling pathway
Jia, L., Liu, J., Ji, Z., Yuan, L., Gong, Y., Jiang, X., Fan, X., Li, C., Li, R., Wang, H., et al. (2026) · Research in Veterinary Science · doi:10.1016/j.rvsc.2026.106165
Almouazen, E. (2013) · theses.fr (ABES) · doi:10.70675/84e17c61z572bz4dc8z9a25zcb156d5c6963 · Cited by 1
“- 36 Figure 11 : Action des rétinoïdes sur différents stades de tumorogénèse (6).”
BackgroundInfluentialToshev, N., Agova, N., Iliev, I., Uzunova, Y. I., Mihalev, K., & Georgieva, S. F. (2026) · Pharmacia · doi:10.3897/pharmacia.73.e188258
Guan, Z., Ao, X., Zhou, L., Yu, C., Zhang, Z., & Li, D. (2026) · ImmunoTargets and Therapy · doi:10.2147/itt.s568661
“15 Upon activation, STAT1 forms homo or heterodimers that translocate to the nucleus, where they drive the transcription of interferon-stimulated genes (ISGs) and play pivotal roles in antiviral defense and tumor suppression.”
Zhang, L., Xiang, G., Zhu, P., Yu, S., Jiang, F., Wang, S., Wang, J., Dai, Y., Wang, S., Tan, Y., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08218-7
“All-trans retinoic acid (ATRA), a derivative of vitamin A, revolutionized the treatment of acute promyelocytic leukemia (APL, also known as FAB-M3 subtype of AML) [3, 4].”
Jabeen, A., Javeed, T., Jan, N., Sofi, S., Masoodi, G., Ahanger, S. A., & Mir, M. A. (2026) · Clinical & Translational Oncology · doi:10.1007/s12094-026-04540-0
Wang, C., Wang, L., & Tsai, F. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl54095
BindingDB Entry 50008667: Novel Fluorescence Competition Assay for Retinoic Acid Binding Proteins.
BindingDB (2021) · UC San Diego · doi:10.7270/q2pn990h
BindingDB Entry 50016852: Ligand recognition by RAR and RXR receptors: binding and selectivity.
BindingDB (2009) · UC San Diego · doi:10.7270/q26d5sj6
BindingDB Entry 50027832: Novel non-carboxylic acid retinoids: 1,2,4-oxadiazol-5-one derivatives.
BindingDB (2010) · UC San Diego · doi:10.7270/q2gf0tc9
BindingDB (2012) · UC San Diego · doi:10.7270/q20r9q7f
BindingDB Entry 50040555: The many faces of the adamantyl group in drug design.
BindingDB (2013) · UC San Diego · doi:10.7270/q22808qq
Acute kidney injury in zebrafish larvae as a regeneration model for drug discovery
Skvarca, L. B. (2015) · D-Scholarship@Pitt (University of Pittsburgh)
Metadata
- Authors
- Altucci, L., & Gronemeyer, H.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Venue
- Nature Reviews Cancer
- Published
- 2001-12
- Volume
- 1
- Issue
- 3
- Pages
- 181-193
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1964224609
- Cited by
- 773
- References
- 147
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 16 · 2023: 18 · 2022: 12 · 2021: 16 · 2020: 20 · 2019: 19 · 2018: 20 · 2017: 28 · 2016: 25 · 2015: 36 · 2014: 25 · 2013: 32 · 2012: 47
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Funders
- Bristol-Myers Squibb
- Institut National de la Santé et de la Recherche Médicale
- Centre National de la Recherche Scientifique
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- retinoids, cancer therapy, cancer prevention, tumor suppression, antiproliferative mechanism, teratogenicity, cell proliferation
- MeSH terms
- Antineoplastic Agents, Cell Differentiation, Forecasting, Humans, Models, Biological, Morphogenesis, Neoplasm Proteins, Neoplasms, Retinoids, Skin Neoplasms, Structure-Activity Relationship, Vitamin A, Leukemia, Promyelocytic, Acute, Oncogene Proteins, Fusion, Transcriptional Activation, Gene Expression Regulation, Neoplastic, Anticarcinogenic Agents, Apoptosis, Receptors, Retinoic Acid, Transcription Factor AP-1, Dimerization, Receptor Cross-Talk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.